Pharmacodynamic Modelling of Biomarker Data in Oncology
Pharmacodynamic Modelling of Biomarker Data in Oncology
About this item
Full title
Author / Creator
Publisher
Cairo, Egypt: Hindawi Puplishing Corporation
Journal title
Language
English
Formats
Publication information
Publisher
Cairo, Egypt: Hindawi Puplishing Corporation
Subjects
More information
Scope and Contents
Contents
The development of pharmacodynamic (PD) biomarkers in oncology has implications for design of clinical protocols from preclinical data and for predicting clinical outcomes from early clinical data. Two classes of biomarkers have received particular attention. Phosphoproteins in biopsy samples are markers of inhibition of signalling pathways, target...
Alternative Titles
Full title
Pharmacodynamic Modelling of Biomarker Data in Oncology
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3302113
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3302113
Other Identifiers
ISSN
2090-5165,2090-5173
E-ISSN
2090-5173
DOI
10.5402/2012/590626
